Medically reviewed by Eland Siddle, PharmD · Last updated July 2026
Most parents don't seek out health information about their child until something feels wrong. That's not a failure of parenting. It's simply how our healthcare system is built. A child has a symptom, a parent calls the doctor, a diagnosis is made. Reactive by design.
Proactive parenting means having information before a problem surfaces, so you can make informed decisions about diet, monitoring, medication safety, and long-term care before you're in crisis mode. Pediatric DNA testing is one of the most useful tools available to do exactly that.
Here's what proactive vs. reactive healthcare looks like for children, and how genetic insight changes the equation.
Reactive vs. Proactive Healthcare: What's the Difference?
Reactive healthcare responds to symptoms after they appear. Proactive healthcare uses available information, including genetic data, to anticipate, prepare, and sometimes prevent. Both have a role; the goal isn't to replace your pediatrician, but to give them more to work with.
| Reactive Approach | Proactive Approach |
|---|---|
| Wait for symptoms before investigating | Screen early, before symptoms appear |
| Diagnose based on clinical presentation | Know genetic risk before clinical signs emerge |
| Trial-and-error with medications | Pharmacogenomic insight guides prescribing |
| Limited context for specialist referrals | Genetic findings can inform specialist conversations |
| Standard well-child monitoring | Targeted monitoring based on individual genetic profile |
| One-time health snapshot | Lifetime genetic record, reanalyzed as science evolves |
What Standard Newborn Screening Does and Doesn't Cover
Every state in the U.S. mandates a newborn screening (NBS) panel, typically performed within 24 to 48 hours of birth. It's an important public health tool, and it saves lives. But it has real limits that parents deserve to understand.
- Scope is narrow. Depending on the state, standard NBS screens for roughly 30 to 80 conditions. Coverage varies significantly by geography.
- It's a one-time snapshot. NBS captures a single moment at birth. Many genetic conditions that affect children don't present until later in childhood.
- No pharmacogenomic insight. Standard NBS doesn't tell you how your child may metabolize medications, information that can matter when a doctor reaches for a prescription.
Standard NBS is a floor, not a ceiling. Proactive parents increasingly want to know more.
What DNA Testing Makes Possible
Earlier Awareness of Genetic Conditions
Comprehensive pediatric genetic screening can identify variants associated with conditions that standard NBS doesn't cover, including conditions that may not become apparent until a child is school-aged or older. That awareness doesn't mean a diagnosis; it means a conversation with your child's doctor can happen sooner, with more information on the table.
Knowing your child carries a variant associated with a metabolic condition, for example, may lead a physician to recommend dietary monitoring before a crisis triggers an ER visit. Learn more about how this kind of screening works in our guide to genetic health screening for new parents.
Medication Safety Before the First Prescription
Pharmacogenomics, the study of how genes affect drug response, is one of the least-discussed but most practical applications of genetic data in pediatric care. Variations in certain genes can affect how a child metabolizes common medications, from ADHD treatments to antibiotics to pain relievers.
Having this information on file before your child ever needs a prescription means their physician can make better-informed choices from the start, rather than adjusting after an unexpected reaction.
Informed Dietary and Lifestyle Planning
Some genetic variants affect how the body processes specific nutrients. In certain cases, early dietary adjustments made with physician guidance can meaningfully support a child's health trajectory. This isn't about following a trend; it's about having the specific data that makes individualized recommendations possible.
A Baseline That Grows With Your Child
A child's genetic profile doesn't change, but scientific understanding of that profile does. With whole genome sequencing, the full picture of your child's DNA is captured once and can be reanalyzed over time as research advances. A variant that has no known clinical significance today may be well-characterized five years from now, with no need for a new sample.
Why Whole Genome Sequencing Is Different From a Panel
Not all genetic tests are the same. Many tests, including most clinical panels, look at a pre-selected list of genes. Whole genome sequencing (WGS) sequences 100% of a child's DNA, not just a targeted subset. That completeness is what enables lifetime reanalysis and broader screening scope.
For a deeper look at what WGS involves and why it matters for children, see our explainer on whole genome sequencing.
Where Fore Fits
Fore Genomics offers a comprehensive, at-home pediatric genetic health screen designed for healthy children. There's no clinic visit, referral, or prescription required. A simple cheek swab is all it takes. The screen uses whole genome sequencing to evaluate 1,000+ genetic conditions and 100+ medication interactions, and it includes board-certified genetic counseling with every result.
Fore is currently the only pediatric product on the market using WGS rather than a limited gene panel. Results are processed in a CLIA-certified, CAP-accredited lab, and your child's genome is stored securely, managed by DNAnexus with military-grade encryption and fully HIPAA-compliant. Because the genome is stored, Fore offers lifetime reanalysis: as science evolves, your child's data can be re-interpreted without collecting a new sample.
For parents who want to understand what happens after results come in, our article on what a genetic counselor does is a good starting point. And if you're weighing whether this kind of screening makes sense for your family, see our honest look at whether pediatric genetic screening is worth it.
If you're ready to learn more, visit www.foregenomics.com.
Personalized Care, Not Prediction
Healthy children are exactly who this kind of screening is designed for.
Traditional medicine tends to ask one question: is my child sick? Fore is built around a different one: how do we help keep them healthy? That shift matters, because a genetic finding is not a diagnosis.
- A variant is not a verdict. Most children who carry one will never develop the associated condition.
- It points to personalized care, not a fixed fate. A finding identifies who may benefit from closer attention, not who is destined to get sick.
- It gives your pediatrician a head start. Depending on the finding, that can mean earlier eye or hearing exams, periodic heart monitoring, earlier cholesterol screening, avoiding a specific medication, or simply noting the result to watch over time.
- The goal isn't predicting the future. It's making your child's care more personalized from day one.
Fore's at-home whole genome screen covers 1,000+ conditions and 100+ medication responses, includes board-certified genetic counseling, and reanalyzes your child's genome over time as science advances. See what Fore screens for.
FAQs
Is pediatric DNA testing only for children with symptoms or a family history?
No. Fore's screen is designed for healthy children with no known diagnosis or family history. The goal is to surface information while a child is well, before symptoms prompt a clinical workup. That said, families with known genetic conditions in their history may find the information especially valuable.
How is this different from the newborn screening my baby already had?
Standard newborn screening is a state-mandated panel that checks for 30 to 80 conditions at birth, depending on the state. Fore's screen uses whole genome sequencing to evaluate 1,000+ conditions and includes pharmacogenomic data (medication interactions) that standard NBS does not provide. It can also be done at any age during childhood, not only at birth.
What happens after we get results?
Every Fore screen includes access to a board-certified genetic counselor who can walk you through what your child's results mean, and what they don't. A genetic counselor can also help you have informed conversations with your child's pediatrician or any relevant specialists.
Does a positive finding mean my child has a condition?
Not necessarily. Genetic variants exist on a spectrum. Some are well-understood; others may indicate increased risk or warrant monitoring rather than treatment. A board-certified genetic counselor and your child's physician are the right resources for interpreting any specific finding and determining next steps.
Is my child's genetic data kept private?
Yes. Fore is HIPAA-compliant, and your child's genome is managed by DNAnexus using military-grade encryption. Fore does not sell genetic data to third parties.